<!--
--
<img width="1620" height="1080" src="https://www.hamiltonhealthsciences.ca/wp-content/uploads/2026/02/Lung-Cancer-Trial-Sharon-Amore-Hamilton-2026.02.03-Web-Size-009-1620x1080.jpg" class="attachment-large size-large wp-post-image"...
<img width="1620" height="1080" src="https://www.hamiltonhealthsciences.ca/wp-content/uploads/2026/02/Lung-Cancer-Trial-Sharon-Amore-Hamilton-2026.02.03-Web-Size-009-1620x1080.jpg" class="attachment-large size-large wp-post-image"...
Boehringer Ingelheim has shared more phase 2 data on its kidney disease candidate apecotrep, shedding light on...
CMTX-101, an antibody-based therapy designed to help clear bacterial lung infections, was tolerated well among people with...
ST. PAUL, Minn., Nov. 6 (UPI) — Positive results from a late-stage clinical trial released...
The study adhered to the ethical principles of the Declaration of Helsinki33 and followed the Strengthening...
